CompletedNCT01884844
Vitamin D Compared With Placebo for Depression in Bipolarity
About this title
Vitamin D Supplementation for Bipolar Depression
Read the official source — NCT01884844Researchers compared Vitamin D3, Cholecalciferol and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Medication studyAges 18–75United States
Understand this study
What did researchers investigate?
Researchers compared Vitamin D3, Cholecalciferol and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- Worcester and 1 more locationSee all locations and recruitment
Study information
Study start dateJune 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 33
- Sponsor
- University of Massachusetts, Worcester
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT01884844
- Official title
Show the full official title
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Worcester
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Vitamin D3, Cholecalciferol and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is University of Massachusetts, Worcester, a university.
Did this study involve medication?
Yes. The study involved medication, including Vitamin D3, Cholecalciferol and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
